EUVIMEDEUVIMED entdecken
Crossref

Panton‐Valentine Leukocidin‐Producing Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan

Ayaka Aoki, Yuko Hatamiya, Hiroko Fukamatsu iD, Seiko Sugiyama iD, Takenobu Yamamoto iD, Yumi Aoyama iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Ayaka Aoki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kawasaki Medical School, Okayama, Japan. Hauptthemen laut MEDLINE: Leukocidins, Exotoxins, Bacterial Toxins, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Panton‐Valentine leukocidin (PVL) is a toxin generally produced by community‐acquired methicillin‐resistant Staphylococcus aureus (CA‐MRSA) that is cytotoxic to neutrophils. USA300 is a virulent epidemic PVL‐producing MRSA clone; it is increasing. Recently, ΨUSA300, a deleted mutant of USA300, has been identified in Japan. However, reports on the clinical and epidemiological characteristics of PVL‐producing MRSA strains, including USA300 and ΨUSA300, remain limited. We included 65 patients who visited our dermatology clinic between January 2020 and May 2024 with skin and soft tissue infections in which CA‐MRSA was detected. Clinical information, antimicrobial susceptibility, PVL production, and MRSA strains were analyzed.PVL, found in 70.8% of patients with CA‐MRSA infection, was more common in younger patients (median age: 34 years) without underlying diseases and was more likely to present with deep‐seated pyoderma (DSP), relapse of clinical symptoms, and intra‐familial outbreaks, with a sepsis‐related complication rate of 4.3%. Patients with PVL‐nonproducing MRSA were anemic and had renal dysfunction. USA300 accounted for 54.3% of the PVL‐producing CA‐MRSA, and 32.0% of USA300 strains were the ΨUSA300 variant. All PVL‐producing CA‐MRSA strains were susceptible to rifampicin and minocycline, whereas most remained susceptible to sulfamethoxazole trimethoprim and fosfomycin. All USA300 strains, including ΨUSA300 strains, were susceptible to gentamicin, whereas 44.4% of PVL‐producing non‐USA300 strains were susceptible.PVL‐producing CA‐MRSA infections commonly present with clinical manifestations of DSP, relapse of clinical symptoms, and intra‐familial outbreaks in younger individuals without underlying diseases and, rarely, with sepsis‐related complications. The increased incidence of USA300 and ΨUSA300 strains in Japan, without differences in age, sex, clinical characteristics, clinical recurrence, intra‐familial outbreaks, and susceptibility to antibiotics, raises concerns regarding the possibility of the global spread of these infections. Given the susceptibility of these strains to gentamicin, nasal application of gentamicin may be a potential strategy to prevent intra‐familial outbreaks and the recurrence of USA300 strains, including ΨUSA300.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukocidinsExotoxinsBacterial ToxinsMethicillin-Resistant Staphylococcus aureusSoft Tissue InfectionsCommunity-Acquired InfectionsStaphylococcal Skin InfectionsHumansJapanMaleFemaleAdultMiddle AgedYoung AdultAgedAnti-Bacterial AgentsAdolescentChildMicrobial Sensitivity TestsChild, PreschoolRetrospective StudiesAged, 80 and overInfantRecurrence

Stichwörter der Autor:innen

Panton‐valentine leukocidinUSA300community‐acquired methicillin‐resistant S. aureusdeep‐seated pyodermarelapse of clinical symptoms

Substanzen

LeukocidinsExotoxinsPanton-Valentine leukocidinBacterial ToxinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
  • Department of Dermatology, Kawasaki Medical School General Medical Center, Okayama, Japan.

ORCID-Profile: Hiroko Fukamatsu, Seiko Sugiyama, Takenobu Yamamoto, Yumi Aoyama

Zitieren

APA

Aoki, A., Hatamiya, Y., Fukamatsu, H., Sugiyama, S., Yamamoto, T., & Aoyama, Y. (2025). Panton‐Valentine Leukocidin‐Producing Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17920

Vancouver

Aoki A, Hatamiya Y, Fukamatsu H, Sugiyama S, Yamamoto T, Aoyama Y. Panton‐Valentine Leukocidin‐Producing Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17920

BibTeX
@article{Aoki2025,
  author = {Aoki, Ayaka and Hatamiya, Yuko and Fukamatsu, Hiroko and Sugiyama, Seiko and Yamamoto, Takenobu and Aoyama, Yumi},
  title = {Panton‐Valentine Leukocidin‐Producing Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17920}
}
Kostenlos starten →